$SNR: New Senior Announces Further Capital Structure Improvement with …

Date: Tuesday, December 18th, 2018

Stock(s) mentioned:

Source: Benzinga (https://www.benzinga.com)

Summary: (NYSE:SNR) announced today that it has paid off $125 million of mortgage debt with a combination of cash on hand and the proceeds from a new revolving …

Full article address: https://www.benzinga.com/pressreleases/18/12/b12871048/new-senior-announces-further-capital-structure-improvement-with-entry-

Related News:

$SNR: New Senior: Don’t Focus On The Headlines

$SNR: The New Senior Investment Group (NYSE:SNR) Share Price Is …

$SNR: New Senior Investment Group’s (SNR) CEO Susan Givens on Q1 …

$SNR: New Senior Investment Group Inc (SNR) Q1 2019 Earnings Call …

$SNR: New Senior Investment Q1 adjusted cash NOI +0.3%

$SNR: New Senior Announces First Quarter 2019 Results

$SNR: New Senior Names Lori B. Marino Executive Vice President …

$SNR: New Senior Investment to get $53M under settlement

$SNR: New Senior Announces First Quarter 2019 Earnings Release Date …

$SNR: New Senior to Participate in Jefferies 2019 Healthcare REIT Summit

$SNR: New Senior Investment Group Inc. (SNR) CEO Susan Givens on Q4 …

Latest News:

$DAL $ALK $LUV $NFLX $UAL: Delta’s test of free in-flight Wi-Fi may shame other airlines into offering service

$AVTR $FSLY $LK $LYFT $PINS $UBER: Why the IPO Boom Will Continue

$SBUX: Millions of Americans Could Miss Work Tomorrow After the ‘Game of Thrones’ Finale

$AMZN $OXY $APC $WFC $SRE: Want to invest like Warren Buffett? Here are the ins and outs of buying preferred stock

$TSLA $GM: Tesla fires could dampen electric car sales as industry ramps up EV production, auto analysts say

$ROKU $GH $CVNA: 3 Stocks That Have Doubled in 2019 — Are They Still Buys?

$AXSM: Here’s Why You’ll Regret Ignoring This Biotech Stock Rocket

$MMM: Market Loses Its Hopium-Induced High, Falls 4 Weeks Straight

$TLRY $ACB: How Did Tilray Stack Up to the Competition?

$BAH: Booz Allen Has Been a Big Winner, but the Best May Be Yet to Come

$ICPT $GILD: Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences